Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

331 ARTÍCULOS , VIENDO DEL 256 AL 270

Alzheimer's disease

Masters CL, Bateman R, Blennow K, Rowe CC, Sperling RA, Cummings JL.

Nat Rev Dis Primers. 2015 Oct 15;1:15056. doi: 10.1038/nrdp.2015.56.

Dementia in 2014. Towards early diagnosis in Alzheimer disease

Nordberg A.

Nat Rev Neurol. 2015 Feb;11(2):69-70. doi: 10.1038/nrneurol.2014.257. Epub 2015 Jan 27.

Amyloid biomarkers in Alzheimer's disease

Blennow K, Mattsson N, Schöll M, Hansson O, Zetterberg H.

Trends Pharmacol Sci. 2015 May;36(5):297-309. doi: 10.1016/j.tips.2015.03.002. Epub 2015 Apr 1.

What lessons can be learned from failed Alzheimer's disease trials?

Toyn J.

Expert Rev Clin Pharmacol. 2015 May;8(3):267-9. doi: 10.1586/17512433.2015.1034690. Epub 2015 Apr 10.

The Worldwide Alzheimer's Disease Neuroimaging Initiative: An update

Hendrix JA, Finger B, Weiner MW, Frisoni GB, Iwatsubo T, Rowe CC, Kim SY, Guinjoan SM, Sevlever G, Carrillo MC.

Alzheimers Dement. 2015 Jul;11(7):850-9. doi: 10.1016/j.jalz.2015.05.008.

LDL-lipids from patients with hypercholesterolaemia and Alzheimer's disease are inflammatory to microvascular endothelial cells: mitigation by statin intervention

Dias HK, Brown CL, Polidori MC, Lip GY, Griffiths HR.

Clin Sci (Lond). 2015 Dec;129(12):1195-206. doi: 10.1042/CS20150351. Epub 2015 Sep 23.

Structural Magnetic Resonance Imaging Markers of Alzheimer's Disease and Its Retranslation to Rodent Models

Kincses ZT, Király A, Veréb D, Vécsei L.

J Alzheimers Dis. 2015;47(2):277-90. doi: 10.3233/JAD-143195.

Correlations between Alzheimer's Disease Cerebrospinal Fluid Biomarkers and Cerebral Glucose Metabolism after 12 Months of Phenserine Treatment

Nordberg A, Kadir A, Andreasen N, Almkvist O, Wall A, Långström B, Zetterberg H.

J Alzheimers Dis. 2015;47(3):691-704. doi: 10.3233/JAD-132474.

Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications

Jha NK, Jha SK, Kumar D, Kejriwal N, Sharma R, Ambasta RK, Kumar P.

J Alzheimers Dis. 2015;48(4):891-917. doi: 10.3233/JAD-150379.

Herbal medicine in the treatment of Alzheimer's disease

Wu JG, Wang YY, Zhang ZL, Yu B.

Chin J Integr Med. 2015 Feb;21(2):102-7. doi: 10.1007/s11655-014-1337-y. Epub 2014 Apr 22.

Polyphenols as therapeutic molecules in Alzheimer's disease through modulating amyloid pathways

Lakey-Beitia J, Berrocal R, Rao KS, Durant AA.

Mol Neurobiol. 2015 Apr;51(2):466-79. doi: 10.1007/s12035-014-8722-9. Epub 2014 May 15.

QT prolongation associated with memantine in Alzheimer's disease

Takehara H, Suzuki Y, Someya T.

Psychiatry Clin Neurosci. 2015 Apr;69(4):239-40. doi: 10.1111/pcn.12236. Epub 2014 Oct 9.

Confirmatory population pharmacokinetic analysis for bapineuzumab phase 3 studies in patients with mild to moderate Alzheimer's disease

Hu C, Adedokun O, Ito K, Raje S, Lu M.

J Clin Pharmacol. 2015 Feb;55(2):221-9. doi: 10.1002/jcph.393. Epub 2014 Sep 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias